TheStreet's Jim Cramer says right now is an opportunity to buy shares of Rite Aid (RAD) because of the major turn going on with an earnings per share revival that stems from sales increases. Rite Aid had a setback on Thursday because of timing issues on the their deal with McKesson (MCK) involving generics. Cramer believes the issue with McKesson will be resolved and that it will not impact earnings results in the second half of 2014. Cramer says Rite Aid’s guidance cut is causing people to panick and sell. Cramer believes the key numbers to focus on were same stores sales figures and pharmacy sales, both of which were good. The issue is the timing. Cramer says investors should buy shares of Rite Aid on any weakness.

If you liked this article you might like

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval

Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree?